Literature DB >> 9566666

Anti-neutrophil cytoplasmic autoantibodies in leprosy.

F Medina1, A Camargo, J Moreno, A Zonana-Nacach, J Aceves-Avila, A Fraga.   

Abstract

The objective was to evaluate the frequency of cytoplasmic and peripheral antineutrophil cytoplasmic antibodies (ANCA) in patients with leprosy, and to correlate the presence of ANCA with type and disease activity. Consecutive patients with leprosy were assessed clinically, and IgG ANCA were measured by indirect immunofluorescence. The presence of three of the following was used to assess disease activity: reactional state, fever, new cutaneous lesions, erythrocyte sedimentation rate and C-reactive protein. Sixty-four patients were studied and divided according to the Ridley-Jopling classification: of 38 patients with lepromatous leprosy, eight (21%) had perinuclear (p) ANCA and two (6%) had cytoplasmic ANCA. ANCA titres ranged from 1:20 to 1:320. Of six borderline leprosy patients, one (16%) had p-ANCA. All 20 tuberculoid leprosy patients and 65 healthy control subjects had negative ANCA. There was no correlation between ANCA titres and disease activity in positive patients. ANCA, mainly those with a perinuclear pattern, may be present in leprosy, especially in the lepromatous pole. This disease should be added to the spectrum of diseases with ANCA positivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566666     DOI: 10.1093/rheumatology/37.3.270

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

Review 1.  Churg-Strauss syndrome.

Authors:  M Conron; H L Beynon
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Effects of anti-endothelial cell antibodies in leprosy and malaria.

Authors:  Christophe Dugué; Ronald Perraut; Pierre Youinou; Yves Renaudineau
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico.

Authors:  María G Zavala-Cerna; Mary Fafutis-Morris; Cecilia Guillen-Vargas; Mario Salazar-Páramo; Diana E García-Cruz; Carlos Riebeling; Arnulfo Nava
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

4.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

5.  Anti-neutrophil cytoplasmic antibodies in leprosy.

Authors:  Fernando Luiz Barros Edington; Maria Olívia Amado Ramos Bacellar; Paulo Roberto Machado; Lúcio Barbosa; Eliana Reis; Mitermayer Reis; Mittermayer Barreto Santiago
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

6.  Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis.

Authors:  I Lima; R C Oliveira; M S Cabral; A Atta; S Marchi; E Reis; M G Reis; L Barbosa; M B Santiago
Journal:  Rheumatol Int       Date:  2014-04-10       Impact factor: 2.631

Review 7.  Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies.

Authors:  Konstantin N Konstantinov; Suzanne N Emil; Marc Barry; Susan Kellie; Antonios H Tzamaloukas
Journal:  ISRN Nephrol       Date:  2013-02-19

8.  CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis.

Authors:  Plinio R Hurtado; Lisa Jeffs; Jodie Nitschke; Mittal Patel; Ghafar Sarvestani; John Cassidy; Pravin Hissaria; David Gillis; Chen Au Peh
Journal:  BMC Immunol       Date:  2008-07-14       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.